Clinical Trials Directory

Trials / Sponsors / Biodel

Biodel

Industry · 16 registered clinical trials.

StatusTrialPhaseStarted
SuspendedA Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diab
Diabetes Mellitus
Phase 22015-05-01
CompletedPharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons
Hypoglycemia
Phase 12014-11-01
CompletedComparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
Type 2 Diabetes Mellitus
Phase 1 / Phase 22014-05-01
CompletedBIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin R
Diabetes Mellitus
Phase 1 / Phase 22014-05-01
CompletedA Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Type 1 Diabetes Mellitus
Phase 22012-08-01
CompletedPharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With T
Type 1 Diabetes
Phase 12012-08-01
CompletedPharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With
Diabetes Mellitus
Phase 12012-02-01
CompletedPharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With
Diabetes Mellitus Type 1
Phase 12011-03-01
CompletedTo Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin Duri
Type 1 Diabetes Mellitus
Phase 32010-02-01
CompletedA Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic an
Diabetes Mellitus
Phase 1 / Phase 22009-07-01
CompletedEffect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Bl
Type 2 Diabetes
Phase 32008-04-01
CompletedAn Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ i
Diabetes Mellitus
Phase 32007-07-01
CompletedAn Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ i
Diabetes Mellitus
Phase 32007-04-01
CompletedAn Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIA
Type 2 Diabetes Mellitus
Phase 32006-12-01
CompletedAn Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIA
Type 1 Diabetes Mellitus
Phase 32006-09-01
CompletedA Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispr
Diabetes Mellitus
Phase 22006-06-01